 您的位置：对照品 > 对照品 > 杂质对照品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：G797705 |
| 产品名称：GSK 461364 |
| 产品CAS：929095-18-1 |
| 规格含量：5mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
G797705 |
| 名称: |
GSK 461364 |
| 别名: |
5-[6-[(4-Methylpiperazin-1-yl)methyl]-1H-benzimidazol-1-yl]-3-[[(1R)-1-[2-(trifluoromethyl)phenyl]ethyl]oxy]thiophene-2-carboxamide; GSK 461364A; |
| CAS号: |
929095-18-1 |
| 分子式: |
C₂₇H₂₈F₃N₅O₂S |
| 分子量: |
543.6 |
| 种类: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
GSK 461364 is a dose-dependant inhibitor of proliferating cancer cell lines as well as an apoptotic agent at higher dosage levels. |
| 参考文献 |
|
|
|
|
|
|
|
|
